105 related articles for article (PubMed ID: 19271688)
1. Quantitative analysis of expression level of BCL2 and BAX genes in Hep-2 and HL-60 cells after treatment with etoposide.
Královcová D; Pejchalová M; Rudolf E; Cervinka M
Acta Medica (Hradec Kralove); 2008; 51(3):191-5. PubMed ID: 19271688
[TBL] [Abstract][Full Text] [Related]
2. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide.
Floros KV; Thomadaki H; Florou D; Talieri M; Scorilas A
Ann N Y Acad Sci; 2006 Dec; 1090():89-97. PubMed ID: 17384250
[TBL] [Abstract][Full Text] [Related]
3. Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol.
Korbakis D; Scorilas A
Tumour Biol; 2012 Jun; 33(3):865-75. PubMed ID: 22238053
[TBL] [Abstract][Full Text] [Related]
4. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12.
Thomadaki H; Floros KV; Scorilas A
Ann N Y Acad Sci; 2009 Aug; 1171():276-83. PubMed ID: 19723066
[TBL] [Abstract][Full Text] [Related]
5. Differential responses of Bcl-2 family genes to etoposide in chronic myeloid leukemia K562 cells.
Fukumi S; Horiguchi-Yamada J; Nakada S; Nagai M; Ohno T; Yamada H
Mol Cell Biochem; 2000 Mar; 206(1-2):43-50. PubMed ID: 10839193
[TBL] [Abstract][Full Text] [Related]
6. Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS.
Thomadaki H; Talieri M; Scorilas A
Biol Chem; 2006 Aug; 387(8):1081-6. PubMed ID: 16895478
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide.
Elliott MJ; Murphy KM; Stribinskiene L; Ranganathan V; Sturges E; Farnsworth ML; Lock RB
Cancer Chemother Pharmacol; 1999; 44(1):1-11. PubMed ID: 10367743
[TBL] [Abstract][Full Text] [Related]
8. Wild-type p53-dependent etoposide-induced apoptosis mediated by caspase-3 activation in human glioma cells.
Yin D; Tamaki N; Kokunai T
J Neurosurg; 2000 Aug; 93(2):289-97. PubMed ID: 10930016
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells.
Perkins C; Kim CN; Fang G; Bhalla KN
Cancer Res; 1998 Oct; 58(20):4561-6. PubMed ID: 9788601
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of Mcl-1 by small interference RNA induces apoptosis and sensitizes HL-60 leukemia cells to etoposide.
Karami H; Baradaran B; Esfehani A; Sakhinia M; Sakhinia E
Asian Pac J Cancer Prev; 2014; 15(2):629-35. PubMed ID: 24568469
[TBL] [Abstract][Full Text] [Related]
11. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
[TBL] [Abstract][Full Text] [Related]
12. mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin.
Floros KV; Thomadaki H; Katsaros N; Talieri M; Scorilas A
Biol Chem; 2004 Nov; 385(11):1099-103. PubMed ID: 15576332
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of nuclear matrix proteins in etoposide induced apoptosis in HL-60 cells.
Jin ML; Zhang P; Ding MX; Yun JP; Chen PF; Chen YH; Chew YQ
Cell Res; 2001 Jun; 11(2):125-34. PubMed ID: 11453544
[TBL] [Abstract][Full Text] [Related]
14. The apoptosis inducing effect of Glycosmis pentaphylla (Retz.) Correa and its influence on gene expression in hepatocellular carcinoma cell line, Hep3 B.
Sreejith PS; Mascarenhas RR; Praseeja RJ; Asha VV
J Ethnopharmacol; 2012 Jan; 139(2):359-65. PubMed ID: 22138516
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors.
Taylor ST; Hickman JA; Dive C
J Natl Cancer Inst; 2000 Jan; 92(1):18-23. PubMed ID: 10620629
[TBL] [Abstract][Full Text] [Related]
16. Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis.
Jia L; Patwari Y; Srinivasula SM; Newland AC; Fernandes-Alnemri T; Alnemri ES; Kelsey SM
Oncogene; 2001 Aug; 20(35):4817-26. PubMed ID: 11521193
[TBL] [Abstract][Full Text] [Related]
17. Induction of leukemia cell apoptosis by cheliensisin A involves down-regulation of Bcl-2 expression.
Zhong L; Li CM; Hao XJ; Lou LG
Acta Pharmacol Sin; 2005 May; 26(5):623-8. PubMed ID: 15842784
[TBL] [Abstract][Full Text] [Related]
18. Phyllanthus urinaria induces the Fas receptor/ligand expression and ceramide-mediated apoptosis in HL-60 cells.
Huang ST; Yang RC; Chen MY; Pang JH
Life Sci; 2004 Jun; 75(3):339-51. PubMed ID: 15135654
[TBL] [Abstract][Full Text] [Related]
19. A role for the subcellular localization of Bax in differentiation-induced resistance to apoptosis in HL-60 cells.
Abdelhaleem M
Anticancer Res; 2002; 22(1A):177-81. PubMed ID: 12017283
[TBL] [Abstract][Full Text] [Related]
20. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
